Valuation: Phosphagenics Limited

Market Cap 76.61M 53.06M 46.62M 43.52M 39.94M 74.77M 5.08B 516M 202M 2.51B 199M 195M 8.69B P/E 2024
-2.5x
P/E 2025 -6.43x
Enterprise Value 71.96M 49.84M 43.79M 40.88M 37.52M 70.23M 4.77B 485M 190M 2.36B 187M 183M 8.17B EV / Sales 2024
5.85x
EV / Sales 2025 23x
Free-Float
76.76%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/05/2020
Chief Operating Officer - 01/05/2020
Corporate Secretary - 01/05/2026
Director TitleAgeSince
Director/Board Member - 13/04/2015
Chairman - 01/01/2019
Director/Board Member 59 26/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-14.29%-14.29% - - 56.13M
-0.87%+4.04%+58.60%+163.92% 1,089B
-0.45%+3.87%+57.95%+52.18% 643B
+0.04%+3.95%+37.69%+74.54% 465B
-1.69%+8.81%+39.38%+34.26% 359B
-0.51%+3.51%+36.97%+43.76% 303B
+1.50%+3.40%+17.71%+18.77% 267B
+0.79%+5.81%-2.55%-36.02% 226B
-1.39%+5.90%+27.70%+64.00% 212B
-1.18%+1.83%+16.20%+72.69% 167B
Average -1.80%+4.77%+32.18%+54.23% 414.57B
Weighted average by Cap. -0.51%+4.90%+41.99%+79.01%

Financials

2024 2025
Net sales 1.13M 785K 689K 643K 591K 1.11M 75.14M 7.63M 2.98M 37.18M 2.95M 2.88M 129M 1.24M 857K 753K 703K 645K 1.21M 82.11M 8.34M 3.26M 40.63M 3.22M 3.15M 140M
Net income -3.12M -2.16M -1.9M -1.77M -1.63M -3.05M -207M -21.03M -8.22M -102M -8.12M -7.94M -354M -4.42M -3.06M -2.69M -2.51M -2.3M -4.31M -293M -29.75M -11.64M -145M -11.49M -11.24M -501M
Net Debt -1.3M -899K -790K -737K -677K -1.27M -86.1M -8.74M -3.42M -42.61M -3.38M -3.3M -147M -4.65M -3.22M -2.83M -2.64M -2.42M -4.54M -308M -31.32M -12.25M -153M -12.09M -11.83M -528M
Logo Phosphagenics Limited
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Employees
-